Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-002642-32Phase 2Completed
Phase 2, single-blind trial of minocycline in acne vulgaris (3 arms), sponsored by Warner Chilcott. Primary endpoint: Reduction in cutaneous Propionibacterium spp. Started Jan 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-002642-32.